SCP
UTHR icon

Sivia Capital Partners’s United Therapeutics UTHR Stock Holding History

Sivia Capital Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$963K Sell
1,778
-844
-32% -$475K 0.12% 207
2026
Q1 		$1.55M Buy
2,622
+517
+25% +$257K 0.3% 76
2025
Q4 		$1.03M Buy
2,105
+1,500
+248% +$699K 0.21% 105
2025
Q3 		$254K Buy
+605
New +$203K 0.07% 380

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sivia Capital Partners's UTHR Position: Q2 2026 in Review

Sivia Capital Partners reduced its United Therapeutics (UTHR) stake by 32% in Q2 2026, selling an estimated $475K and leaving 1,778 shares worth $963K. The position accounts for 0.12% of the portfolio, ranked #207.

Sivia Capital Partners first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.55M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sivia Capital Partners held 1,778 shares of United Therapeutics worth $963K as of Q2 2026.
  • Sivia Capital Partners sold 844 United Therapeutics shares in Q2 2026, an estimated $475K.
  • United Therapeutics made up 0.12% of Sivia Capital Partners's portfolio in Q2 2026, its #207 holding.
  • Sivia Capital Partners first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Sivia Capital Partners's United Therapeutics position peaked at $1.55M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.